乙型肝炎病毒和抗原 (HBeAg) 的VHL独立降解,由VHL结合的化学小分子降解
Liam T Hales1, Simon J Mountford1, Mina Takawy2
1Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University Parkville 3052 Australia philip.thompson@monash.edu.
RSC medicinal chemistry
|April 25, 2025
概括
针对乙型肝炎病毒和抗原 (HBeAg) 的新降解剂在治疗慢性HBV感染方面表现有前途. 这些化合物有效地降低了HBeAg水平,并显示出对抗性病毒菌株的增强疗效.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 乙型肝炎病毒 (HBV) 导致全球肝癌负担显著.
- 目前的治疗方法对慢性HBV感染缺乏持久的疗效.
- HBV e抗原 (HBeAg) 抑制免疫反应,其损失表明病毒清除.
研究的目的:
- 研究HBeAg的向蛋白质降解.
- 开发针对慢性HBV的新型治疗策略.
- 探索HBeAg作为药物点,因为它与HBcAg相似.
主要方法:
- 使用HBcAg配体设计的异构生物功能降解剂.
- 使用了VHL E3结合酶招募策略.
- 在HiBiT记者测定中评估了HBeAg减少.
- 对野生型和耐药HBV菌株的评估化合物疗效.
主要成果:
- 多种化合物降低了复合HBeAg水平.
- 减少HBeAg是由VH032连接物动图驱动的,独立于VHL招募.
- 化合物显示出与父母抑制剂相比,分泌的HBeAg具有同实力降低.
- 观察到抗抑制剂耐药HBV菌株的疗效增加.
结论:
- 证明了将HBV体连接物转化为降解剂的可行性.
- 提供了证据,证明降解剂对突变,耐药HBV菌株的活性有所改善.
- 突出了慢性HBV治疗中新型治疗方法的潜力.
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


